Literature DB >> 20789884

Hyperpyrexia During Treatment with Methyldopa.

V M Montegriffo.   

Abstract

Entities:  

Year:  1963        PMID： 20789884      PMCID： PMC1872117          DOI： 10.1136/bmj.2.5348.35

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  7 in total

1.  Treatment of severe hypertension with methyldopa.

Authors:  M HAMILTON; H KOPELMAN
Journal:  Br Med J       Date:  1963-01-19

2.  Hypotensive action methyldopa.

Authors:  H SMIRK
Journal:  Br Med J       Date:  1963-01-19

3.  Methyldopa in the treatment of hypertension.

Authors:  R I BAYLISS; E A HARVEY-SMITH
Journal:  Lancet       Date:  1962-04-14       Impact factor: 79.321

4.  Methyldopa in hypertension. Clinical and pharmacological studies.

Authors:  C T DOLLERY; M HARINGTON
Journal:  Lancet       Date:  1962-04-14       Impact factor: 79.321

5.  Clinical and chemical studies with alpha-methyl-dopa in patients with hypertension.

Authors:  L GILLESPIE; J A OATES; J R CROUT; A SJOERDSMA
Journal:  Circulation       Date:  1962-02       Impact factor: 29.690

6.  Clinical pharmacology of newer anthypertensive agents, monoamine oxidase and decarboxylase inhibitors, bretvlium tosvlate, and guanethidine.

Authors:  L GILLESPIE
Journal:  Ann N Y Acad Sci       Date:  1960-10-11       Impact factor: 5.691

7.  Agranulocytosis caused by methyl dopa (Aldomet).

Authors:  G P HALLWRIGHT
Journal:  N Z Med J       Date:  1961-12
  7 in total
  2 in total

1.  PARKINSONISM ASSOCIATED WITH ALPHA-METHYLDOPA THERAPY.

Authors:  M J PEASTON
Journal:  Br Med J       Date:  1964-07-18

2.  Treatment of hypertension with methyldopa.

Authors:  P Johnson; A H Kitchin; C P Lowther; R W Turner
Journal:  Br Med J       Date:  1966-01-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.